J. Pfeilschifter

发表

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

A. LaCroix, C. Cooper, S. Boonen, 2011, Bone.

Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women.

R. Ziegler, J. Pfeilschifter, C. Scheidt-Nave, 1996, The Journal of clinical endocrinology and metabolism.

Obesity is not protective against fracture in postmenopausal women: GLOW.

Julie Flahive, Kenneth G Saag, Steven Boonen, 2011, The American journal of medicine.

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.

G. Bastert, M. Seibel, J. Pfeilschifter, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals.

W. Rascher, R. Ziegler, J. Pfeilschifter, 1998, European journal of endocrinology.

Positive association between circulating free thyroxine and insulin‐like growth factor I concentrations in euthyroid elderly individuals

R. Ziegler, J. Pfeilschifter, C. Scheidt-Nave, 1998, Clinical endocrinology.

Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells.

G. Mundy, J. Pfeilschifter, S. D'souza, 1987, Endocrinology.

Chemotactic response of osteoblastlike cells to transforming growth factorβ

R. Ziegler, G. Mundy, J. Pfeilschifter, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sex Steroids and Bone

R. Ziegler, J. Pfeilschifter, M. Bräutigam, 1994, Ernst Schering Research Foundation Workshop.

Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

M. Seibel, R. Ziegler, J. Pfeilschifter, 2001, The Journal of clinical endocrinology and metabolism.

Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH‐deficient adults

R. Ziegler, J. Pfeilschifter, C. Wüster, 2001, Clinical endocrinology.

Low serum concentrations of insulin‐like growth factor I are associated with femoral bone loss in a population‐based sample of postmenopausal women

R. Ziegler, J. Pfeilschifter, C. Scheidt-Nave, 2001, Clinical endocrinology.

Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

G. Mundy, J. Pfeilschifter, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age

R. Ziegler, J. Pfeilschifter, I. Diel, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

A. LaCroix, C. Cooper, S. Boonen, 2012, Bone.

Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women

A. LaCroix, N. Watts, R. Lindsay, 2012, Journal of the American Geriatrics Society.

[Postmenopausal and steroid-induced osteoporosis guideline-orientated prevention and treatment].

J. Pfeilschifter, 2005, Der Internist.

Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2013, Calcified Tissue International.

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

R. Ziegler, R. Krempien, J. Pfeilschifter, 1999, Bone.

Severe Osteoporosis in Familial Hajdu–Cheney Syndrome: Progression of Acro‐Osteolysis and Osteoporosis During Long‐Term Follow‐up

B. Limberg, R. Ziegler, J. Pfeilschifter, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.

G. Mundy, J. Pfeilschifter, S. Seyedin, 1988, The Journal of clinical investigation.

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.

A. LaCroix, C. Cooper, S. Boonen, 2010, Mayo Clinic proceedings.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

A. LaCroix, D. Hosmer, C. Cooper, 2014, Osteoporosis International.

[Osteoporosis: prophylaxis, diagnostics and therapy according to the guidelines].

U. Müller-Ladner, J. Pfeilschifter, U. Lange, 2011, Der Internist.

[Diagnosing osteoporosis: what is new in the 2014 DVO guideline?].

J. Pfeilschifter, 2015, Deutsche medizinische Wochenschrift.

Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.

C. Cooper, S. Silverman, S. Boonen, 2012, Bone.

Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women

A. LaCroix, C. Cooper, A. Díez-Pérez, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Interleukin‐1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

C. Chenu, G. Mundy, J. Pfeilschifter, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of angiotensin II on bone cells in vitro

M. Schrader, R. Ziegler, J. Pfeilschifter, 1998, Journal of cellular physiology.

2006 DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines.

J. Pfeilschifter, 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.

R. Ziegler, J. Pfeilschifter, W. Blum, 1998, The Journal of clinical endocrinology and metabolism.

Transforming growth factor β (TGF-β) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-β in human bone matrix in vivo

R. Ziegler, J. Pfeilschifter, I. Diel, 1999 .

Regional Differences in Incident Prefrailty and Frailty

A. LaCroix, C. Cooper, A. Díez-Pérez, 2017 .

Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro.

R. Ziegler, J. Pfeilschifter, T. Seck, 2001, Bone.

Role of Growth Factors in Cartilage and Bone Metabolism

L. Bonewald, G. Mundy, J. Pfeilschifter, 1990 .

[Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006].

J. Pfeilschifter, A. Kurth, 2007, Der Orthopade.

[Prevalence of thyroid gland dysfunctions in 50- to 80-year-old patients. An epidemiologic cross-sectional study in a southwestern community].

R. Ziegler, J. Pfeilschifter, C. Scheidt-Nave, 1997, Medizinische Klinik.

International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study

C. Cooper, S. Silverman, A. Díez-Pérez, 2014, Osteoporosis International.

Role of cytokines in postmenopausal bone loss

J. Pfeilschifter, 2003, Current osteoporosis reports.

Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.

R. Ziegler, J. Pfeilschifter, W. Blum, 1995, The Journal of clinical investigation.

Differential effects of platelet-derived growth factor isoforms on plasminogen activator activity in fetal rat osteoblasts due to isoform-specific receptor functions.

R. Ziegler, R. Krempien, J. Pfeilschifter, 1992, Endocrinology.

Oxidized low-density lipoprotein in post-menopausal women

J. Jankowski, V. Jankowski, J. Pfeilschifter, 2015 .

Oxidized low-density lipoprotein in postmenopausal women

J. Jankowski, V. Jankowski, J. Pfeilschifter, 2014, Journal of hypertension.

Assessment of Levothyroxine Sodium Bioavailability

K. Wegscheider, I. Walter‐Sack, J. Pfeilschifter, 2004, Clinical pharmacokinetics.

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications

N. Freemantle, R. Horne, C. Cooper, 2010, Archives of osteoporosis.

Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement.

R. Ziegler, J. Pfeilschifter, I. Diel, 1995, The Journal of clinical endocrinology and metabolism.

Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age

S. Mohan, R. Ziegler, J. Pfeilschifter, 2000, Mechanisms of Ageing and Development.

Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption

R. Ziegler, J. Pfeilschifter, 1996, Clinical endocrinology.

Association of Transforming Growth Factor-b1 (TGFb1) T29?C Gene Polymorphism with Bone Mineral Density (BMD), Changes in BMD, and Serum Concentrations of TGF-b1 in a Population-Based Sample of Postmenopausal German Women

R. Ziegler, J. Pfeilschifter, C. Scheidt-Nave, 2001, Calcified Tissue International.

Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.

R. Ziegler, J. Pfeilschifter, H. Minne, 1990, Endocrinology.

Performance evaluation of automated assays for β-CrossLaps, N-MID-Osteocalcin and intact parathyroidhormone (BIOROSE Multicenter Study)

D. Felsenberg, J. Pfeilschifter, F. Raue, 2004, Clinical chemistry and laboratory medicine.

Changes in the Concentration of Insulin-Like Growth Factor I and Transforming Growth Factor β1 in Rat Femoral Bone during Growth

R. Ziegler, J. Pfeilschifter, M. Weinreb, 2014, Calcified Tissue International.

Assessment of sex hormone-binding globulin and osteocalcin in patients undergoing coronary artery bypass graft surgery.

E. Martin, J. Pfeilschifter, J. Motsch, 2000, Journal of cardiothoracic and vascular anesthesia.

Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix.

F. Bauss, R. Ziegler, J. Pfeilschifter, 1998, Bone.

Characterization of the latent transforming growth factor ß complex in Bone

L. Bonewald, G. Mundy, J. Pfeilschifter, 1990, Journal of Bone and Mineral Research.

Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo.

R. Ziegler, J. Pfeilschifter, I. Diel, 1999, Bone.

Cytokines and signal transduction

J. Pfeilschifter, 1994, The clinical investigator.

Transforming Growth Factor Beta als Mediator bei Gewebsumbauprozessen

J. Pfeilschifter, 1988 .

Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta.

R. Ziegler, J. Pfeilschifter, H. Minne, 1990, Endocrinology.

Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass.

R. Ziegler, J. Pfeilschifter, S. Scharla, 1984, Endocrinology.

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

G. Roodman, C. Chenu, G. Mundy, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Changes in proinflammatory cytokine activity after menopause.

J. Pfeilschifter, M. Pfohl, H. Schatz, 2002, Endocrine reviews.

Cytokines as mediators of hypercalcemia of malignancy.

J. Pfeilschifter, 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women.

R. Ziegler, J. Pfeilschifter, I. Diel, 2002, Bone.

Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples.

R. Ziegler, J. Pfeilschifter, I. Diel, 2001, European journal of endocrinology.

Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume

R Krempien, R. Krempien, J. Pfeilschifter, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bisphosphonate drug holidays: Risk of fractures and mortality in a prospective cohort study.

J. Pfeilschifter, H. Trampisch, I. Steinebach, 2020, Bone.

Characterization of the latent transforming growth factor ß complex in Bone

L. Bonewald, G. Mundy, J. Pfeilschifter, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW)

C. Cooper, S. Boonen, A. Díez-Pérez, 2012, Annals of the rheumatic diseases.

Transforming Growth Factor-β

J. Pfeilschifter, 1990 .

Osteoporosis due to cancer treatment: pathogenesis and management.

J. Pfeilschifter, I. Diel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frailty and Fracture, Disability, and Falls: A Multiple Country Study From the Global Longitudinal Study of Osteoporosis in Women

A. LaCroix, C. Cooper, S. Boonen, 2013, Journal of the American Geriatrics Society.

Transforming growth factor beta (TGF-β) increases plasminogen activator (PA) activity in osteoblast-like cell cultures from fetal rat calvariae

R. Ziegler, J. Pfeilschifter, H. Minne, 1989 .

[Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].

R. Ziegler, J. Pfeilschifter, 1998, Medizinische Klinik.

When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Nelson B. Watts, Steven Boonen, Jonathan D. Adachi, 2013, PloS one.

Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women

A. LaCroix, C. Cooper, S. Boonen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.

U. Roggenbuck, R. Hoermann, J. Pfeilschifter, 2002, Thyroid.

Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.

R. Ziegler, J. Pfeilschifter, 1997, European journal of endocrinology.

Age-associated changes in the stimulatory effect of transforming growth factor beta on human osteogenic colony formation

R. Ziegler, J. Pfeilschifter, I. Diel, 1999, Mechanisms of Ageing and Development.

[Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease].

R. Ziegler, J. Pfeilschifter, S. Haufe, 1997, Nuklearmedizin. Nuclear medicine.

Impact of Pretreatment Variables on the Outcome of [131]I Therapy with a Standardized Dose of 150 Gray in Graves' Disease

R. Ziegler, J. Pfeilschifter, S. Haufe, 1997 .

Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism.

R. Ziegler, J. Pfeilschifter, C. Wüster, 1992, Acta endocrinologica.

Self-perception of fracture risk: what can it tell us?

A. LaCroix, C. Cooper, S. Silverman, 2017, Osteoporosis International.

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

A. LaCroix, C. Cooper, S. Silverman, 2009, Osteoporosis International.

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

A. LaCroix, D. Hosmer, C. Cooper, 2014, The Journal of clinical endocrinology and metabolism.

Differing risk profiles for individual fracture sites: Evidence from the global longitudinal study of osteoporosis in women (GLOW)

A. LaCroix, D. Hosmer, S. Boonen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Predicting fractures in an international cohort using risk factor algorithms without BMD

A. LaCroix, D. Hosmer, C. Cooper, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

A. LaCroix, C. Cooper, S. Silverman, 2013, Osteoporosis International.

Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation

R. Ziegler, J. Pfeilschifter, H. Minne, 1987, Calcified Tissue International.

Inflammation-mediated osteopenia in the rat: the effects of artificial granuloma and sham operation on cortical and trabecular bone.

R. Ziegler, J. Pfeilschifter, H. Minne, 1985, Bone.

Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study

N. Freemantle, R. Horne, C. Cooper, 2013, Osteoporosis International.

Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis.

R. Ziegler, J. Pfeilschifter, H. Minne, 2004, European journal of endocrinology.

Relationship between IGF-I and skeletal aging.

R. Ziegler, J. Pfeilschifter, 1998, European journal of endocrinology.

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2010, Osteoporosis International.

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis

D. Felsenberg, J. Pfeilschifter, H. Kruse, 2004, Current medical research and opinion.

Osteoporose Update

J. Pfeilschifter, 2011, Osteologie.

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

FRACTURE PATTERNS WITH SELECTIVE SEROTONIN RECEPTOR INHIBITOR, PROTON PUMP INHIBITOR AND GLUCOCORTICOIDS USE IN GLOW

A. LaCroix, C. Cooper, S. Silverman, 2014 .

New horizons for the in vivo assessment of major aspects of bone quality

Y. Lu, G. Huber, M. Morlock, 2013, Osteologie.

Cardiovascular Death and the Metabolic Syndrome

E. Barrett-Connor, C. Langenberg, J. Pfeilschifter, 2006, Diabetes Care.

The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone.

R. Ziegler, J. Pfeilschifter, T. Seck, 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy].

K. Müller, J. Pfeilschifter, M. Krieg, 2002, Medizinische Klinik.

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

G. Roodman, C. Chenu, G. Mundy, 1988, Proceedings of the National Academy of Sciences of the United States of America.

[Osteoporosis in Germany, 2003 -- a stock taking].

J. Pfeilschifter, C. Scheidt-Nave, L. Pientka, 2003, MMW Fortschritte der Medizin.

Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C

R. Ziegler, J. Pfeilschifter, F. Raue, 1992 .

Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells*

G. Mundy, J. Pfeilschifter, S. D'souza, 1987 .

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.

J. Pfeilschifter, G. R. Mundy, S. M. Seyedin, 1988, The Journal of clinical investigation.

Impact of Prevalent Fractures on Quality of Life: Baseline Results from the Global Longitudinal Study of Osteoporosis in Women Repository Citation

E. Siris, K. Saag, F. Hooven, 2022 .

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

D. Hosmer, A. Díez-Pérez, L. March, 2014, The Journal of clinical endocrinology and metabolism.